Ventyx Biosciences Inc (VTYX) Stock Price

9.25 ▼ -0.30 (-3.14%)
Open: 9.22 Vol: 2.72M Day's range: 8.98 - 9.85 Nov 14, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
VTYX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
NEUTRAL SELL SELL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 9.19▲ 9.24▼ 9.22▲ 9.40▼ 7.26▲
MA10 9.18▲ 9.31▼ 9.38▼ 9.03▲ 5.10▲
MA20 9.23▲ 9.40▼ 9.42▼ 7.61▲ 3.91▲
MA50 9.28▼ 9.47▼ 9.20▲ 4.90▲ 2.65▲
MA100 9.41▼ 9.17▲ 8.60▲ 3.78▲ 2.99▲
MA200 9.41▼ 8.40▲ 6.45▲ 2.67▲ 14.07▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.002▲ -0.031▼ -0.059▼ 0.033▲ 0.710▲
RSI 49.621▼ 44.130▼ 46.681▼ 72.910▲ 88.207▲
STOCH 41.686     27.927     28.468     79.296     82.178▲
WILL %R -55.556     -71.779     -71.779     -20.499▲ -9.567▲
CCI -11.438     -77.453     -108.462▼ 73.785     162.647▲
Latest Filters Detected On VTYX
MA $VTYX Price Crossed Below MA(7) Set Alert
▼ GAP $VTYX Open Gap Down %3 Set Alert
▼ GAP $VTYX Open Gap Down %2 Set Alert
CDL $VTYX Doji Candlestick Pattern Detected Set Alert
Ventyx Biosciences Inc News
Oppenheimer Sticks to Their Buy Rating for Ventyx Biosciences (VTYX)
Wednesday, November 12, 2025 04:11 PM
Detailed price information for Ventyx Biosciences Inc (VTYX-Q) from The Globe and Mail including charting and trades.
Ventyx Biosciences: Why Caution Should Remain
Tuesday, November 11, 2025 01:12 PM
Ventyx Biosciences' VTX3232 showed promising anti-inflammatory Phase 2 results, but financial risks remain. Click here to read my most recent analysis.
Ventyx Biosciences Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Progress
Thursday, November 06, 2025 01:41 PM
Data from the recent Phase 2 study position Ventyx’s NLRP3 inhibitor VTX3232 as a next generation, oral anti-inflammatory therapy, for cardiovascular disease Positive topline data from Phase 2a ...
VTYX historical stock data
date open high low close volume
14/11/25 9.22 9.85 8.98 9.25 2,715,997
13/11/25 9.35 9.70 9.1738 9.55 2,098,211
12/11/25 9.46 9.99 9.28 9.51 1,597,050
11/11/25 9.125 9.80 8.77 9.43 2,192,171
10/11/25 9.01 9.50 8.69 9.24 2,171,084
07/11/25 9.26 9.39 8.155 8.77 2,639,229
06/11/25 8.99 9.46 8.69 9.26 3,114,681
05/11/25 8.59 9.23 8.27 9.00 3,491,171
04/11/25 7.87 8.528 7.80 8.09 2,113,757
03/11/25 8.38 8.64 7.92 8.23 3,038,800
Quote Details
52wk Low:0.783
52wk High:9.99
Vol:2.72M
Avg Vol(3m):74.8M
1Y Chng:+267.06%
1M Chng:+147.99%
Add to Watch List
More Information
Index US Composite
Market Cap. 681.48M